Genentech discovers possible prenatal clue to Alzheimer's disease

Researchers at Genentech proposed that N-APP, a fragment of the amyloid precursor protein, causes the death of nerve cells and fibers in Alzheimer's patients by triggering a process that destroys the cells. This normally happens during prenatal development to get rid of excess cells, but Genentech scientists found that the process can somehow reactivate during adulthood.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC